Cargando...

Septoprim Trimetoprim Sulfametoxazol - Contenido de 100 ml Suspensión

data:image/png;base64,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

    Clase Terapeutica

  • INFECTOLOGÍA

    • Acciones Terapeuticas

  • ANTIPROTOZOOARIO
  • ANTIMICROBIANO

    • Principios Activos

  • TRIMETOPRIM
  • SULFAMETOXAZOL

    • Concentración

  • TRIMETOPRIM 40 MG
  • SULFAMETOXAZOL 200 MG

    • Presentación

  • SUSPENSION

Mas Info

Está indicado para el tratamiento o prevenciones de infecciones pulmonares causadas por el Pneumocystis jiroveci (P.carinii)

- Tratar la Shigellosis causada por cepas susceptibles de Shigella flexneri y Shigella sonnei cuando esté indicada una terapia antibacteriana.

- Tratar o prevenir la toxoplasmosis, causada por carne poco cocinada o heces de gato.

- Tratar la nocardiosis, una infección bacteriana que da lugar a abscesos.

- Tratar infecciones del tracto urinario, como las cistitis o brotes de empeoramiento de la bronquitis crónica.

- Tratar infecciones del oído, como las otitis media aguda

También te puede interesar

Septoprim Forte Trimetoprim 160mg Sulfametoxazol 800mg - Cont. 18 comprimidos

QUIMIOTERÁPICO, BACTERICIDA DE AMPLIO ESPECTRO

TRIMETOPRIM, SULFAMETOXAZOL

Uro-Septoprim - Cont. 24 Comprimidos

ANALGESICO DE LAS VIAS URINARIAS, QUIMIOTERÁPICO, BACTERICIDA DE AMPLIO ESPECTRO

TRIMETOPRIM, SULFAMETOXAZOL, FENAZOPIRIDINA



CALIDAD

Estamos comprometidos con la salud de las personas.

SOSTENIBILIDAD

Producción comprometida con el futuro.

PROFESIONALISMO

Equipo profesional especializado.